STEMI India: reimagining STEMI networks in low- and middle-income countries

Effective treatment for ST-elevation myocardial infarction (STEMI) includes the 24/7 availability of reperfusion therapy, which is crucial for good clinical outcomes. In low- and middle-income countries, this is hindered by disparities in resource utilisation, irregularities in access to health care and organisational gaps. Due to the inaccessibility of primary percutaneous coronary intervention (PCI) for most patients, the more feasible and practical approach of pharmacoinvasive management must be incorporated into the systems of care for STEMI. This review focuses on the development of STEMI India, a not-for-profit organisation that aims to advance the field of STEMI management by imparting and disseminating the latest information from around the world on STEMI management to all those involved in STEMI care. The STEMI India model system of care includes a 3-model framework, based on infrastructure and workforce availability, and tailored to meet the needs of the society it caters to. After the successful implementation of the “Tamil Nadu STEMI” project, a nationwide system of care for STEMI has been developed, which has been endorsed by the Cardiological Society of India (CSI) and

[1]  W. O’Neill,et al.  Racial, Ethnic, and Sex Disparities in Patients With STEMI and Cardiogenic Shock. , 2021, JACC. Cardiovascular interventions.

[2]  R. Janapati,et al.  National interventional council data for the year 2018-India , 2020, Indian heart journal.

[3]  Jeroen J. Bax,et al.  Resource and Infrastructure-Appropriate Management of ST-Segment Elevation Myocardial Infarction in Low- and Middle-Income Countries , 2020, Circulation.

[4]  U. Khot,et al.  Economic and Societal Impact of a Systems-of-Care Approach for STEMI Management in Low and Middle-Income Countries: Insights from the TN STEMI Program , 2019, Annals of global health.

[5]  Alan D. Lopez,et al.  Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015 , 2017, Journal of the American College of Cardiology.

[6]  C. Ayers,et al.  A System of Care for Patients With ST-Segment Elevation Myocardial Infarction in India: The Tamil Nadu–ST-Segment Elevation Myocardial Infarction Program , 2017, JAMA cardiology.

[7]  A. Mullasari,et al.  Two-year follow-up data from the STEPP-AMI study: A prospective, observational, multicenter study comparing tenecteplase-facilitated PCI versus primary PCI in Indian patients with STEMI. , 2016, Indian heart journal.

[8]  B. Nallamothu,et al.  Framework for a National STEMI Program: consensus document developed by STEMI INDIA, Cardiological Society of India and Association Physicians of India. , 2015, Indian heart journal.

[9]  B. Nallamothu,et al.  Protocol for a prospective, controlled study of assertive and timely reperfusion for patients with ST-segment elevation myocardial infarction in Tamil Nadu: the TN-STEMI programme , 2013, BMJ Open.

[10]  P. Armstrong,et al.  Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction. , 2013, The New England journal of medicine.

[11]  W. Wijns,et al.  Stent for Life: how this initiative began? , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[12]  B. Nallamothu,et al.  Systems of care for ST-elevation myocardial infarction in India , 2011, Heart.

[13]  Access Investigators Management of acute coronary syndromes in developing countries: acute coronary events-a multinational survey of current management strategies. , 2011, American heart journal.

[14]  S. Yusuf,et al.  Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data , 2008, The Lancet.

[15]  B. Gersh Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data , 2009 .